Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloprotein
about
Glycosylation of matrix metalloproteases and tissue inhibitors: present state, challenges and opportunitiesEffect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trialResearch Progress on the Risk Factors and Outcomes of Human Carotid Atherosclerotic Plaques.Imaging atherosclerosis and vulnerable plaque.Detection of altered extracellular matrix in surface layers of unstable carotid plaque: an optical spectroscopy, birefringence and microarray genetic analysis.Inhibitory effects of vinpocetine on the progression of atherosclerosis are mediated by Akt/NF-κB dependent mechanisms in apoE-/- miceCaveolin-1 influences vascular protease activity and is a potential stabilizing factor in human atherosclerotic disease.Importance of N-glycosylation on CD147 for its biological functionsLysophosphatidic Acid Is Associated with Atherosclerotic Plaque Instability by Regulating NF-κB Dependent Matrix Metalloproteinase-9 Expression via LPA2 in Macrophages.ADAMTS-7 is associated with a high-risk plaque phenotype in human atherosclerosis.Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study.Emerging applications of nanotechnology for the diagnosis and management of vulnerable atherosclerotic plaques.A fluorescence lifetime spectroscopy study of matrix metalloproteinases-2 and -9 in human atherosclerotic plaque.Carotid atherosclerotic plaques: proteomics study after a low-abundance protein enrichment step.Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages.Relationship of MMP-14 and TIMP-3 expression with macrophage activation and human atherosclerotic plaque vulnerability.Nitroglycerin alters matrix remodeling proteins in THP-1 human macrophages and plasma metalloproteinase activity in rats.Interferon-gamma increases the ratio of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 in peripheral monocytes from patients with coronary artery diseaseFunctional relevance of protein glycosylation to the pro-inflammatory effects of extracellular matrix metalloproteinase inducer (EMMPRIN) on monocytes/macrophagesSpecific matrix metalloproteinases play different roles in intraplaque angiogenesis and plaque instability in rabbits.Fibroblast activation protein is induced by inflammation and degrades type I collagen in thin-cap fibroatheromata.Changes in plasma profiles of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in stress-induced cardiomyopathyBlockade of Ets-1 attenuates epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.Possible Mechanisms of Di(2-ethylhexyl) Phthalate-Induced MMP-2 and MMP-9 Expression in A7r5 Rat Vascular Smooth Muscle Cells.Carotid atherosclerotic plaque matrix metalloproteinase-12-positive macrophage subpopulation predicts adverse outcome after endarterectomy.Role of matrix metalloproteinase-8 in atherosclerosisCyclic strain-mediated matrix metalloproteinase regulation within the vascular endothelium: a force to be reckoned with.Distribution of Matrix Metalloproteinases in Human Atherosclerotic Carotid Plaques and Their Production by Smooth Muscle Cells and Macrophage SubsetsTumor necrosis factor-α regulates triggering receptor expressed on myeloid cells-1-dependent matrix metalloproteinases in the carotid plaques of symptomatic patients with carotid stenosisPentosan polysulfate inhibits atherosclerosis in Watanabe heritable hyperlipidemic rabbits: differential modulation of metalloproteinase-2 and -9Metalloproteinases and vulnerable atherosclerotic plaquesDifferential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass.10-years experience with the Athero-Express study.MMP-1 and MMP-9 regulate epidermal growth factor-dependent collagen loss in human carotid plaque smooth muscle cells.Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaquesImaging and molecular biomarkers of vulnerable atheromatous plaques.Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology.The roles of CD147 in the progression of gliomas.Neutrophil proteolytic activation cascades: a possible mechanistic link between chronic periodontitis and coronary heart disease.Metalloproteinase production from macrophages - a perfect storm leading to atherosclerotic plaque rupture and myocardial infarction.
P2860
Q26745510-4B367B65-E2BA-4758-B044-CE2708E58008Q28539991-584E42FE-D2F6-41D7-BE5F-1374FC5539FFQ30235230-16502B06-1520-4AAF-9514-B14A3A7066BDQ30435383-886C4C31-BF2D-4CF0-B608-C2790731A725Q31019927-B1657F37-D997-4574-9AF3-C6EC3332558FQ31146253-21C380AA-BF4B-4508-8562-955677B18BE7Q33348628-96946F4D-DDDF-4CD9-9E1D-20ED412AA1BAQ33580673-012E444A-3BB7-4BDE-9187-EB12D33D5589Q33607215-BEDB36C6-7977-47AB-A6B8-938EFE250BF1Q33808002-DA05398A-C31A-4305-9A4C-83C4E1105F6FQ33813502-75CECCB4-2CC7-4A43-8157-8D55FD459071Q33839384-11B59A59-FA93-46D7-B4FD-1C5C35BC3D85Q33965165-0BEC8310-E82E-4D77-B046-316DF13E2E31Q34144310-577F230D-1606-4D9B-B831-0162F435E5EAQ34167795-98C746EC-AAE9-4179-ADDE-4D06D2F0220EQ34175955-2C5C183F-DCB0-4A41-935A-A730DC6803D2Q34574503-C07EAB08-E7C9-4D85-BDD1-EBCF84C6C4CBQ34951441-82E376F4-615B-4CCA-B595-2F41BF2D1499Q35058275-56DB7D02-6987-4D31-A7E8-DEC87E52BE3BQ35261656-27691715-41B5-4168-9C38-60BBFD8B8729Q35492880-2F36C25A-C2C3-4809-B836-11ABF8A1943FQ35992781-1B28D470-9D81-46DC-B8A5-33799009CC2CQ36114066-56667C1D-6BC6-41F2-A8AB-94331DF525A6Q36404088-FA2A96C6-157A-4103-A7AD-30422BA29662Q36519765-2AD4160C-E3CF-44C9-B176-E6EC1A389261Q36567357-B34D4549-C5F0-4DDA-9A20-3F7C923AC270Q36584877-3BF5E793-8314-438C-9D99-75283161EF74Q36665727-4915D406-D365-49F4-877A-517E4FCBBA7EQ36813491-23A75F92-3013-40FE-8385-346755AB5978Q36999082-90CA63BF-1EB4-4CC0-A126-85945ACC3875Q37005370-39D4848D-9F48-4158-ACB3-2C51B9017387Q37151445-6AE11E80-9713-486D-A6BD-84D388316311Q37339333-09C3F3FF-96B3-45CB-9323-CBFEDFFA2BA0Q37664093-0AC4540C-2D99-4713-BA2E-BEE1AE9AA05CQ37730682-1D0652B6-B0EA-4D05-9B81-4DFBD1AE4AE3Q37755125-D2712597-B42A-4630-BC21-E317D51744F1Q38052020-0200D693-EE5D-4813-83B2-46FF2985AE56Q38594492-9D384A46-17F7-4454-899C-B4CE16AB854EQ38648056-7344C6C9-1B01-4786-9049-97A1E8B0D5C3Q38771095-B903DD01-9F2B-4A0F-9B44-CBEF8D518593
P2860
Matrix metalloproteinase 2 is associated with stable and matrix metalloproteinases 8 and 9 with vulnerable carotid atherosclerotic lesions: a study in human endarterectomy specimen pointing to a role for different extracellular matrix metalloprotein
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Matrix metalloproteinase 2 is ...... cellular matrix metalloprotein
@en
type
label
Matrix metalloproteinase 2 is ...... cellular matrix metalloprotein
@en
prefLabel
Matrix metalloproteinase 2 is ...... cellular matrix metalloprotein
@en
P2093
P50
P1433
P1476
Matrix metalloproteinase 2 is ...... cellular matrix metalloprotein
@en
P2093
Arjan H Schoneveld
Chaylendra F Strijder
Dominique P V de Kleijn
Evelyn Velema
Frans Moll
Jan Verheijen
Jean-Paul de Vries
Joost P G Sluijter
Roeland Hanemaaijer
Wilco P C Pulskens
P304
P356
10.1161/01.STR.0000196986.50059.E0
P407
P577
2005-12-08T00:00:00Z